Skip to main content
. 2014 Dec;5(6):401–407. doi: 10.3978/j.issn.2078-6891.2014.053

Table 1. Patient and tumor characteristics for all CEC patients treated with definitive CRT (n=37).

Patient characters Tumor
Number Percent (%)
Gender
   Male 22 59
   Female 15 41
Age
   Range 27-88
   Median 67
Tobacco abuse (lifetime)
   Yes 27 73
   No 10 27
Alcohol abuse (lifetime)
   Yes 16 43
   No 21 57
T-component
   T1 5 14
   T2 13 35
   T3 14 38
   T4 5 14
N-component
   N0 17 46
   N1 14 38
   N2 6 16
   N3 0 0
Tumor length (cm)
   Range 2-13
   Mean 4.4
Tumor HPV 16/18 status
   HPV positive 1/19 5
   HPV negative 18/19 95
Tumor p16 status
   p16 positive 3/18 17
   p16 negative 15/18 83
Radiation dose
   <40 Gy 3 8
   ≥40 Gy, <50 Gy 7 19
   ≥50 Gy, <60 Gy 12 32
   ≥60 Gy, <70 Gy 11 30
   ≥70 Gy 4 11
Concurrent chemotherapy regimen
   CDDP/5-FU 16 43
   CDDP 4 11
   CDDP/VP-16 6 16
   CDDP/Taxol 6 16
   Other 5 14

CEC, cervical esophageal carcinoma; CRT, chemoradiotherapy.